MoneyWorks4Me

Beryl Drugs informs about SAST updates

19 Aug 2026 Evaluate
Beryl Drugs has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1846.45
Dr. Reddys Labs. 1212.60
Cipla 1370.90
Lupin 2122.40
Zydus Lifesciences 1172.70
View more..